Specialty Pharmacy

Endo and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in New York.

Emphascience will develop the product exclusively for Upsher-Smith, which will manufacture, market and distribute it under its own label in the United States.

After having led for 10 years, Makov is retiring as Sun Pharma's chairman and member of the board.

Amber Specialty Pharmacy will begin dispensing 13 Pfizer oncology products.

Ztalmy is the only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder in patients 2 years of age and older.

In May 2022, prescribers used Real-Time Prescription Benefit to save patients an average of $534.74 per specialty prescription.

Sun Pharma and Cassiopea will bring Winlevi to patients in Japan, Australia, New Zealand, Brazil, Mexico and Russia.

Hyftor is used to treat facial angiofibroma associated with tuberous sclerosis complex for patients 6 years and older.

The Hy-Vee subsidiary will offer Evusheld at its 19 locations throughout the U.S.

Walgreens announced full ownership of the company in January, necessitating the name change.

Mallinckrodt issued 13,170,932 new ordinary shares to its guaranteed unsecured noteholders.

The company is offering Lyvispah, a baclofen oral granules specialty product, and bexarotene gel, 1%.